Publications
View AllAnagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
Key Points Noninferiority of anagrelide in comparison with hydroxyurea in WHO-essential thrombocythemia, a phase 3 trial
Institution Info
- Type
- facility
- Country
- AT
- Publications
- 3
- Citations
- 1,133
External Links
Identifiers
- ROR
- https://ror.org/02z2dfb58